Grants and Contracts Details
Description
Abstract
There remain challenges with retaining persons with opioid use disorder (OUD) in treatment with
buprenorphine. Tirzepatide is a new medication with a novel mechanism of action that may be help patients
stay retained in treatment when added to buprenorphine pharmacotherapy.
| Status | Active |
|---|---|
| Effective start/end date | 3/1/25 → 2/29/28 |
Funding
- University of Cincinnati: $69,120.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.